Evidence map›Paper›PMID 28220831›Full record

ArticleScientific reports2017

The distribution of the apparent diffusion coefficient as an indicator of the response to chemotherapeutics in ovarian tumour xenografts.

Monique C Tourell, Ali Shokoohmand, Marietta Landgraf, Nina P Holzapfel, Patrina S P Poh, Daniela Loessner, Konstantin I Momot

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Role of Calixarene in Chemotherapy Delivery Strategies.Molecules (Basel, Switzerland) · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Clinical translation of [European journal of nuclear medicine and molecular imaging · 2018
    Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Monique C TourellQueensland University of Technology (QUT), Brisbane, Queensland (QLD), Australia.
Ali ShokoohmandQueensland University of Technology (QUT), Brisbane, Queensland (QLD), Australia.
Marietta LandgrafQueensland University of Technology (QUT), Brisbane, Queensland (QLD), Australia.
Nina P HolzapfelQueensland University of Technology (QUT), Brisbane, Queensland (QLD), Australia.
Patrina S P PohExperimental Trauma Surgery, Department of Trauma Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Daniela LoessnerQueensland University of Technology (QUT), Brisbane, Queensland (QLD), Australia.
Konstantin I MomotQueensland University of Technology (QUT), Brisbane, Queensland (QLD), Australia.
Queensland University of Technology · AUTechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diffusion-weighted magnetic resonance imaging (DW-MRI) was used to evaluate the effects of single-agent and combination treatment regimens in a spheroid-based animal model of ovarian cancer. Ovarian tumour xenografts grown in non-obese diabetic/severe-combined-immunodeficiency (NOD/SCID) mice were treated with carboplatin or paclitaxel, or combination carboplatin/paclitaxel chemotherapy regimens. After 4 weeks of treatment, tumours were extracted and underwent DW-MRI, mechanical testing, immunohistochemical and gene expression analyses. The distribution of the apparent diffusion coefficient (ADC) exhibited an upward shift as a result of each treatment regimen. The 99-th percentile of the ADC distribution ("maximum ADC") exhibited a strong correlation with the tumour size (r

Indexed as

AnimalsAntineoplastic AgentsCarboplatinDiffusion Magnetic Resonance ImagingDrug Therapy, CombinationElastic ModulusExtracellular MatrixExtracellular Matrix ProteinsFemaleGene Expression Regulation, NeoplasticHumansMiceMice, Inbred NODMice, SCIDOvarian NeoplasmsPaclitaxelAntineoplastic AgentsCarboplatinExtracellular Matrix ProteinsPaclitaxel

Identifiers

PMID28220831
PMCPMC5318900
OpenAlexW2589979388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.